Avanza Fonder Ab Abbott Laboratories Transaction History
Avanza Fonder Ab
- $3.05 Trillion
- Q1 2025
A detailed history of Avanza Fonder Ab transactions in Abbott Laboratories stock. As of the latest transaction made, Avanza Fonder Ab holds 167,746 shares of ABT stock, worth $22.4 Million. This represents 0.73% of its overall portfolio holdings.
Number of Shares
167,746
Previous 182,445
8.06%
Holding current value
$22.4 Million
Previous $20.6 Billion
7.24%
% of portfolio
0.73%
Previous 0.61%
Shares
2 transactions
Others Institutions Holding ABT
# of Institutions
3,541Shares Held
1.38BCall Options Held
9.75MPut Options Held
8.87M-
Vanguard Group Inc Valley Forge, PA170MShares$22.7 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.5 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.4 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.93 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.78 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $234B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...